SWA
ALXN

Stratos Wealth Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Stratos Wealth Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,778
Closed -$272K – 256
2019
Q3 		$272K Buy
2,778
+314
+13% +$30.7K 0.1% 200
2019
Q2 		$323K Sell
2,464
-9
-0.4% -$1.18K 0.13% 164
2019
Q1 		$334K Buy
+2,473
New +$334K 0.18% 145